Section Arrow
Quote
DRUG.NASDAQ
- Bright Minds Biosciences
Quotes are at least 15-min delayed:2026/02/19 19:18 EST
After Hours
Last
 83
-3.08 (-3.58%)
Bid
79.1
Ask
83.99
High 86.08 
Low 79.01 
Volume 768 
Regular Hours (Closed)
Last
 86.08
+5.78 (+7.20%)
Day High 
86.55 
Prev. Close
80.3 
1-M High
91 
Volume 
117.59K 
Bid
79.1
Ask
83.99
Day Low
78 
Open
79.21 
1-M Low
72.075 
Market Cap 
781.49M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 77.54 
20-SMA 80.26 
50-SMA 83.14 
52-W High 123.75 
52-W Low 23.175 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.76/-8.76
Enterprise Value
781.53M
Balance Sheet
Book Value Per Share
6.74
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TOVXTheriva Biologics Inc0.1967+0.0047+2.45%0.09PE
After Hours 0.1891 -0.0076 -3.86%
IBRXImmunityBio8.61+0.07+0.82%-- 
After Hours 8.5 -0.11 -1.28%
DRMADermata Therapeutics Inc1.93+0.65+50.78%0.08PE
After Hours 1.8099 -0.1201 -6.22%
QNCXQuince Therapeutics0.1622-0.0158-8.88%-- 
After Hours 0.163 +0.0008 +0.49%
LIMNLiminatus Pharma Inc0.2383-0.0066-2.69%-- 
After Hours 0.237 -0.0013 -0.55%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.